RestorixHealth, a top company in wound care in the United States, recently announced the successful purchase of CÅ«tisCare, a company that specializes in multi-place hyperbaric medicine and managing outpatient wound centers in hospitals. This merger positions both companies as a key partner for managing wound and hyperbaric centers across the country. The acquisition helps RestorixHealth improve its ability to set new standards in wound care and offer more services to its partners.
Health Technology Insights: ExaCare AI Raises $30 Million to Transform Nursing Admissions
By bringing together CÅ«tisCare’s knowledge in hyperbaric medicine with RestorixHealth’s strengths in operations, finances, and clinical care, the organization is better equipped to serve healthcare partners and explore future growth. This combination brings a deep understanding of both mono-place and multi-place hyperbaric treatments, giving hospitals the support needed to run successful hyperbaric units.
RestorixHealth also plans to invest more in wound care research and clinical results by working with top medical and academic institutions. These efforts will help continue developing effective treatment methods that improve patient healing and support care that is backed by scientific evidence. The expanded support includes teams focused on operations, finances, and marketing to help hospital partners manage their centers efficiently.
Health Technology Insights: Microsoft Expands Dragon Copilot AI for Nurses and Partners
Ben Dunford, CEO of RestorixHealth, said that combining CÅ«tisCare with RestorixHealth’s services makes the company better at serving hospitals of all sizes, whether in rural or urban areas, and at academic medical centers. He said the merger will help expand access to quality care for patients with hard-to-heal wounds and support hospital partners in achieving better results. Dr. William H. Tettelbach, Chief Medical Officer, added that the combination provides healthcare partners with more clinical expertise, allowing providers to offer safer, more effective care that reduces complications and prevents amputations.
Jared Golub, Chairman of the Board of RestorixHealth and Partner at Marblegate Asset Management, said the acquisition helps establish RestorixHealth as a national leader in wound care and strengthens its ability to provide high-quality services while maintaining excellent patient outcomes. By adding CÅ«tisCare’s hospital, academic medical center, and health system partners, including UCLA Medical Center, UC San Diego Health, and Yale New Haven Health, RestorixHealth now works with almost 300 partners in 41 states. The transaction does not include RegenQuest, CÅ«tisCare’s division that focuses on office-based wound care and hyperbaric programs, which will continue to operate on its own.
Health Technology Insights: INITIO Medical Named First ICPO Theranostics Center in North America
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
